See more : Zodiac Clothing Company Limited (ZODIACLOTH.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Nuveen Select Tax-Free Income Portfolio (NXP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nuveen Select Tax-Free Income Portfolio, a leading company in the Asset Management – Income industry within the Financial Services sector.
- Inspur International Limited (0596.HK) Income Statement Analysis – Financial Results
- Pidilite Industries Limited (PIDILITIND.BO) Income Statement Analysis – Financial Results
- Zalemark Holding Company Inc. (ZMRK) Income Statement Analysis – Financial Results
- The Liberty Braves Group (BATRB) Income Statement Analysis – Financial Results
- Helbiz, Inc. (HLBZ) Income Statement Analysis – Financial Results
Nuveen Select Tax-Free Income Portfolio (NXP)
Industry: Asset Management - Income
Sector: Financial Services
Website: https://www.nuveen.com/CEF/Product/Overview.aspx?fundcode=NXP
About Nuveen Select Tax-Free Income Portfolio
Nuveen Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of United States. The fund invests in the investment-grade municipal securities rated Baa and BBB or better. It benchmarks the performance of its portfolio against the Standard & Poor's (S&P) National Municipal Bond Index and Lipper General and Insured Unleveraged Municipal Debt Funds Average. Nuveen Select Tax-Free Income Portfolio was formed on March 19, 1992 and is domiciled in the United States.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 30.18M | 77.20K | -43.69M | 18.68M | 13.60M | 15.59M | 11.40M | 11.04M | 7.03M | 10.70M | 11.56M | 12.20M | 0.00 |
Cost of Revenue | 0.00 | -25.39M | -58.70M | 8.21M | 3.35M | 5.48M | 613.82K | 626.77K | 625.32K | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 30.18M | 25.47M | 15.01M | 10.47M | 10.25M | 10.10M | 10.78M | 10.42M | 6.40M | 10.70M | 11.56M | 12.20M | 0.00 |
Gross Profit Ratio | 100.00% | 32,995.86% | -34.35% | 56.05% | 75.37% | 64.82% | 94.61% | 94.33% | 91.10% | 100.00% | 100.00% | 100.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.57M | 350.27K | 204.38K | 155.05K | 157.13K | 142.12K | 162.01K | 716.08K | 705.98K | 796.55K | 684.41K | 696.50K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.57M | 350.27K | 204.38K | 155.05K | 157.13K | 142.12K | 162.01K | 716.08K | 705.98K | 796.55K | 684.41K | 696.50K | 0.00 |
Other Expenses | 0.00 | -15.14M | 9.41K | 8.50K | 9.29K | 10.03K | 11.79K | 0.00 | 7.85M | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 1.57M | 376.40K | 213.78K | 163.55K | 166.41K | 152.15K | 173.80K | 8.87M | -7.85M | 13.93M | 10.78M | 7.23M | 0.00 |
Cost & Expenses | 1.57M | -25.77M | -59.14M | 8.04M | 3.18M | 5.33M | 173.80K | 9.64M | -7.22M | 13.93M | 10.78M | 7.23M | 0.00 |
Interest Income | 30.18M | 4.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 262.94K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 19.59K | 4.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 366.48K | 2.30M | 233.86K | 0.00 | 0.00 |
Depreciation & Amortization | -28.61M | -23.84M | -14.00M | -9.77M | -9.55M | -9.44M | -9.26M | -9.30M | -9.68M | -9.91M | -10.88M | -11.50M | 0.00 |
EBITDA | 0.00 | -24.14M | 0.00 | 8.74M | 3.88M | 5.99M | 0.00 | 1.41M | 4.57M | 0.00 | 0.00 | 7.92M | 0.00 |
EBITDA Ratio | 0.00% | -31,273.37% | 133.04% | 46.81% | 28.53% | 38.44% | 98.47% | 12.75% | 202.73% | 116.15% | -89.36% | 64.97% | 0.00% |
Operating Income | 28.61M | 23.84M | 14.00M | 9.77M | 9.55M | 9.44M | 11.22M | 1.41M | 14.25M | 9.91M | 10.88M | 11.50M | 0.00 |
Operating Income Ratio | 94.79% | 30,880.07% | -32.04% | 52.32% | 70.25% | 60.58% | 98.47% | 12.75% | 202.73% | 92.56% | 94.08% | 94.29% | 0.00% |
Total Other Income/Expenses | 2.79M | -25.69M | -161.53M | 8.74M | 3.88M | 5.99M | 0.00 | -7.89M | -6.00 | 12.43M | -10.33M | 7.92M | 0.00 |
Income Before Tax | 31.40M | -299.20K | -44.13M | 18.51M | 13.43M | 15.43M | 11.22M | 1.41M | 14.25M | 22.34M | 545.58K | 19.42M | 0.00 |
Income Before Tax Ratio | 104.04% | -387.57% | 101.00% | 99.12% | 98.78% | 99.02% | 98.47% | 12.75% | 202.73% | 208.71% | 4.72% | 159.26% | 0.00% |
Income Tax Expense | 0.00 | -24.14M | -58.13M | 8.74M | 3.88M | 5.99M | 9.26M | -7.89M | 4.21M | 10.13M | -10.57M | 7.92M | 0.00 |
Net Income | 31.40M | -299.20K | -44.13M | 18.51M | 13.43M | 15.43M | 11.22M | 1.41M | 14.25M | 22.34M | 545.58K | 19.42M | 0.00 |
Net Income Ratio | 104.04% | -387.57% | 101.00% | 99.12% | 98.78% | 99.02% | 98.47% | 12.75% | 202.73% | 208.71% | 4.72% | 159.26% | 0.00% |
EPS | 0.65 | -0.01 | -0.94 | 1.12 | 0.81 | 0.94 | 0.68 | 0.09 | 0.86 | 1.35 | 0.03 | 1.17 | 0.00 |
EPS Diluted | 0.65 | -0.01 | -0.94 | 1.12 | 0.81 | 0.94 | 0.67 | 0.09 | 0.86 | 1.35 | 0.03 | 1.17 | 0.00 |
Weighted Avg Shares Out | 47.94M | 46.80M | 46.80M | 16.59M | 16.58M | 16.42M | 16.57M | 16.57M | 16.57M | 16.57M | 16.57M | 16.57M | 16.51M |
Weighted Avg Shares Out (Dil) | 47.94M | 46.80M | 46.80M | 16.59M | 16.58M | 16.42M | 16.75M | 16.57M | 16.57M | 16.57M | 16.57M | 16.57M | 16.51M |
NXP Combines Ultra-Wideband Secure Ranging and Short-Range Radar to Enable Autonomous Industrial and IoT Applications
NXP Semiconductors Announces Quarterly Dividend and Additional Share Repurchase Authorization
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
NXP Semiconductors to Host 2024 Investor Day
NXP Semi Stock Is A Buy On Weakness, Most Attractive Analog Name In Space: Analyst
NXP Sinks. Wall Street Is Still Mostly Optimistic About Apple's Chip Maker.
NXP Semiconductors Posts Mixed Q2 Results, Joins Medpace And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
NXP Stock Slumps After Chipmaker Issues Soft Outlook—Watch This Key Price Level
NXP Semi forecasts third-quarter revenue below estimates on auto weakness
NXP Semiconductors Reports Second Quarter 2024 Results
Source: https://incomestatements.info
Category: Stock Reports